Phosphatidylcholine (PC)
3 is a major component of cellular membranes, and an important constituent of serum lipoproteins and pulmonary surfactant. PC is formed from diacylglycerol by a de novo pathway that was originally described by Kennedy in 1961 (1) . PC can also be generated by LPC remodeling. The rapid turnover of the sn-2 acyl moiety of glycerophospholipids was described by Lands (Lands' cycle) (2) (3) (4) , and is attributed to activation of phospholipase A 2 s and lysophospholipid acyltransferases. Although these metabolic processes are carried out in a variety of different tissues, the enzyme molecule(s) involved in LPC remodeling have not been identified. We previously cloned 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic acid, LPA) acyltransferase (LPAAT), and found that the enzyme used LPA as an acceptor (5) . Whereas the recombinant enzyme utilized various fatty acyl-CoAs as acyl donors, no other lysophospholipid served as an acceptor. Several lysophospholipid acyltransferases have been cloned in the last decade (6 -24) , and putative LPAATs (␣, ␤, ␥, ␦, ⑀, and ) and tafazzins have been identified (5, 12-16, 18, 22-26) . However, LPCAT, the most important enzyme in membrane biogenesis and surfactant production, has not yet been isolated. Using previously proposed acyltransferase motifs (27) , and an extensive genomic data base search as well as 5Ј-and 3Ј-rapid amplification of cDNA ends, we identified a candidate Lpcat gene. The enzyme was highly expressed in the lung, in particular in alveolar type II cells, and it possessed a catalytic preference for the production of di-saturated PC. Thus, we propose that this enzyme plays a critical role in the production of surfactant lipids. To our knowledge, this is the first documentation of a cDNA for LPCAT, a critically important enzyme in the biogenesis of membrane phospholipids and surfactant lipids. We termed the enzyme LPCAT1. [1- 14 C]Palmitoyl-CoA (2.22 GBq/mmol), [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]palmitoyl-LPC (2.07 GBq/mmol), and horseradish peroxidase-linked anti-mouse IgG were from Amersham Biosciences. Four amidinophenylmethanesulfonyl fluoride, M2 and M5 anti-FLAG mouse monoclonal antibody, Dulbecco's modified Eagle's medium, and linoleoyl-CoA (C18:2) were purchased from Sigma. A proteinase inhibitor mixture, Complete, was from Roche. TLC silica gel plates (type 5721) were purchased from Merck (Darmstadt, Germany). Alexa Fluor 546 goat anti-mouse IgG, LysoTracker Red DND-99, and MitoTracker Red CMXRos were purchased from Molecular Probes, Inc. (Eugene, OR). An anti-calnexin antibody was from BD Biosciences (Tokyo, Japan). Various lysophospholipids and acyl-CoAs were obtained from Avanti Polar Lipids (Alabaster, AL).
EXPERIMENTAL PROCEDURES

Materials
Cloning of Acyl-CoA:LPC Acyltransferase 1 (LPCAT1)
The mouse lysophospholipid acyltransferase gene was identified based upon sequence similarity to the C terminus of the Lpaat gene through a comprehensive BLAST search. A 1.6-kb cDNA clone encoding the full-length mouse Lpcat1 (LPCAT1, DDBJ accession number AB244717) was cloned by PCR amplification using the forward primer 5Ј-CTAGCTAGCCACCAT-GGATTACAAGGATGACGATGACAAGAGGCTGCGGG-GCCGCGGGCCGCGG-3Ј, the reverse primer 5Ј-CCGCTCG-AGCTAGTCCGCTTTCTTACAAGAATTC-3Ј, and a mouse spleen cDNA library as a template. The FLAG epitope (DYKD-DDDK) was attached to the N terminus of mLpcat1 using PCR, and a forward primer that encoded the FLAG sequence inframe with the start codon of the mLpcat1 coding region. Amplification was carried out for 5 cycles of 96°C for 15 s, 40°C for 20 s, and 68°C for 1.75 min, followed by 30 cycles of 96°C for 15 s, 60°C for 20 s, and 68°C for 1.75 min. Amplified PCR products were cloned into the pCXN2.1 vector (28) and sequenced. Similarly, human and rat LPCAT1 cDNAs (DDBJ accession numbers AB244719 and AB244983, respectively) were amplified by PCR and inserted into the pCXN2.1 vector.
Quantitative Real-time RT-PCR
Mouse total RNA was prepared from various tissues using Absolutely RNA Miniprep Kit (Stratagene, La Jolla CA), and first strand cDNAs were synthesized using Superscript II (Invitrogen, Tokyo, Japan). PCR were carried out in microcapillary tubes, in 20-l reaction volumes consisting of 2 l of cDNA solution, 1ϫ FastStart DNA Master SYBR Green I (Roche Applied Science), and 0.5 M each of the forward and reverse primer. A 163-bp fragment of mLpcat1 or rat Lpcat1 was generated using the following primers: forward primer, 5Ј-GTGCACGAGCTGCGACT-3Ј; reverse primer, 5Ј-GCTG-CTCTGGCTCCTTATCA-3Ј. A 227-bp fragment of rat surfactant protein-C was generated using the following primers: forward primer, 5Ј-CTCCACTGGCATCGTTCT-3Ј; reverse primer, 5Ј-CTCGCCCAGAAGAATCAG-3Ј.
Expression of FLAG-mLPCAT1 in CHO-K1 Cells
FLAG-tagged mLpcat1 was constructed by ligating the FLAG-tagged cDNA (as described above) into the NheI-XhoI site of pCXN2.1. DNA transfection of CHO-K1 cells was performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions, and cells were harvested 48 h post-transfection.
Confocal Microscopy
CHO-K1 cells were seeded onto 6-cm dishes at a density of 8 ϫ 10 5 cells/dish 1 day before transfection. Six g each of pCXN2.1 vector or FLAG-mLpcat1-pCXN2.1 were transfected using Lipofectamine 2000. 48 h post-transfection, pCXN2.1 vector-or FLAG-mLPCAT1-pCXN2.1-transfected cells were incubated with 2.5 g/ml DiOC 6 (3) (Invitrogen) and 10 g/ml M5 anti-FLAG mouse monoclonal antibody (Sigma) in 1/4ϫ Permeabilization Buffer (Beckman). After washing, cells were incubated with 10 g/ml Alexa Fluor 546 goat anti-mouse IgG (Eugene, OR) for 30 min. pEGFP-C1 vector-or pEGFP-mLP-CAT1-transfected cells were stained with 100 nM MitoTracker Red CMXRos or 50 nM LysoTracker Red DND-99 in Hanks' balanced salt solution containing 10 mM HEPES (pH 7.4) and 0.1% bovine serum albumin at 37°C for 30 min. Confocal microscopy was performed with an LSM510 Laser Scanning Microscope (Carl Zeiss, Germany) equipped with a 63ϫ waterimmersion objective lens (NA ϭ 1.2). FLAG-mLPCAT1, MitoTracker Red, and LysoTracker Red were monitored by excitation at 543 nm with a He/Ne laser, and by emission with a 585-nm long path filter. For the detection of DiOC 6 (3) and GFP fluorescence, the excitation was at 488 nm with an argon laser, and emissions were taken with a 505-550-nm band pass filter.
Western Blot Analysis
One g of total cellular protein was resolved by 10% SDS-PAGE and transferred to a Hybond ECL nitrocellulose membrane (Amersham Biosciences). The membrane was blocked with 5% skim milk, incubated with M2 anti-FLAG mouse monoclonal antibody, washed, and then incubated with horseradish peroxidase-linked anti-mouse IgG (Amersham Biosciences). After washing, the membranes were exposed to ECL reagents (Amersham Biosciences) and x-ray film (Amersham Biosciences) to visualize immunoreactive proteins. 7 g of total cellular protein was analyzed by Western blot using an anticalnexin antibody as an endoplasmic reticulum (ER) marker.
Assay of Lysophospholipid Acyltransferase
For the preparation of cell extracts, cells in 10-cm dishes were scraped into 1 ml of ice-cold buffer containing 20 mM Tris-HCl (pH 7.4), 300 mM sucrose, and a proteinase inhibitor mixture, Complete, then sonicated three times on ice for 30 s. After centrifugations for 10 min at 800 and 9,000 ϫ g, the supernatant was collected and centrifuged at 100,000 ϫ g for 1 h. The resulting pellet was resuspended in buffer containing 20 mM Tris-HCl (pH 7.4), 300 mM sucrose, and 1 mM EDTA. Protein concentration was measured by the method of Bradford (29), using a protein assay solution (Bio-Rad) and bovine serum albumin (fraction V, fatty acid-free, Sigma) as a standard. The acyltransferase activity was measured in two ways: (i) conversion of [1- 14 C]palmitoyl-LPC (293 MBq/mmol) to PC in the presence of acyl-CoA and (ii) the transfer of [1- 14 C]palmitoyl-CoA (293 MBq/mmol) to lysophospholipids to form phospholipids. Reaction mixtures contained 100 mM Tris-HCl (pH 7.4), 1 mM EDTA, 1 mg/ml PC, the indicated concentrations of acyl-CoA and lysophospholipid, and enzyme in a total volume of 0.1 ml. After incubation at 30°C for 5 min, reactions were stopped by the addition of 0.3 ml of chloroform:methanol (1:2, v/v). Total lipid was extracted by the Bligh-Dyer method (30) , and subsequently analyzed by TLC in chloroform:methanol:acetic acid: water (50:25:8:4, v/v). Bands at positions corresponding to the expected product were visualized by I 2 vapor, cut off the plate, placed in Microscinti-O (PerkinElmer Life Sciences), and analyzed in a liquid scintillation counter LS6500 (Beckman).
Isolation of Rat Alveolar Type II Cells
Cells were isolated by the method of Dobbs and Mason (31) . In brief, 6 -8-week-old Sprague-Dawley (200 -250 g body weight) rats were injected intraperitoneally with heparin and pentobarbital. The heart-lung preparation was perfused with buffer A consisting of 140 mM NaCl, 5 mM KCl, 2.5 mM sodium potassium phosphate, 10 mM HEPES (pH 7.4), 1 mg/ml glucose, and 10 mg/ml gentamycin. The lungs were removed en block from the thoracic cavity and washed five times with buffer A. Lavage fluids were collected and centrifuged to obtain alveolar macrophages, which were used as a negative control in these experiments. After washing, a fluorocarbon (Sumitomo 3M, Tokyo, Japan)-albumin emulsion was injected intratracheally, and the lung was incubated at 37°C for 30 min. This step facilitated the separation of alveolar macrophages from alveolar type II cells. After extensive washing with buffer containing 2 mM EGTA, the lung was injected intratracheally with about 40 ml of elastase solution (porcine pancreas elastase, 4.3 units/ml, Worthington, Lakewood, NJ). The lung was minced into 1-mm 3 pieces, shaken vigorously during incubation at 37°C for 5 min, and cells released from the lung were recovered through nylon gauzes. Type II alveolar epithelial cells were isolated from the upper layer of a metrizamide density gradient, washed with buffer A containing 2 mM CaCl 2 and 1.3 mM MgSO 4, and incubated in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. The fraction contained Ͼ90% alveolar type II cells. These cells were quickly frozen, and subsequently used for RT-PCR or enzymatic analyses.
Microscopic Analyses
Transmission Electron Microscopy-Alveolar type II cells freshly isolated from rat lungs were seeded on aclar film (Nisshin EM, Tokyo, Japan) and incubated overnight. The cells were then fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). After a brief wash with the same buffer, postfixation with 1% OsO 4 Ϫ in 0.1 M phosphate buffer was carried out for 2 h, followed by gradual dehydration with ethanol. The cells were embedded in Epon. Thin serial sections (90-nm thickness) were stained with uranyl acetate and lead citrate. The samples were examined at 100 kV with a HITACHI H-7100s (HITACHI, Tokyo, Japan).
Differential Interference Contrast Microscopy-2 ϫ 10 6 rat alveolar type II cells were seeded on a 35-mm glass-bottomed dish (IWAKI) and incubated overnight. The cells were rinsed with Dulbecco's modified Eagle's medium and mounted into a CO 2 incubator placed on the stage of an inverted microscope (Carl Zeiss LSM 510 system) 30 min before the observation.
Animals
All animal studies were conducted in accordance with the guidelines for animal research at The University of Tokyo and were approved by The University of Tokyo Ethics Committee for Animal Experiments.
RESULTS
Identification and Cloning of LPCAT1-The mouse Lpcat1
gene was identified based upon sequence homology with previously reported lysophospholipid acyltransferases, including a putative mouse Lpaat gene. A 1.6-kb cDNA clone encoding the full-length mouse LPCAT1 enzyme was obtained by PCR amplification. The putative open reading frame of mLPCAT1 encoded a 534-amino acid protein of 59.8 kDa, containing three transmembrane domains and several conserved motifs found in members of the lysophospholipid acyltransferase family (5, 12-16, 20, 21, 26, 27) . The presence of a C-terminal sequence motif (KKXX) indicated that the enzyme localizes to the ER (32). mLPCAT1 exhibited 88.2 and 98.1% amino acid sequence identity to human and rat LPCAT1, respectively (Fig. 1) . The protein contained a putative EF-hand-like motif (from amino acids 380 to 480) (33), but we found no obvious Ca 2ϩ requirement for catalytic activity (see below).
Tissue Distribution of mLPCAT1 mRNA-The tissue distribution of mLpcat1 was analyzed by quantitative real-time RT-PCR. We found the highest level of mLpcat1 expression in the lung, followed by spleen and brain. Other tissues had very low expression levels of mLpcat1 (Fig. 2) .
Subcellular Localization of FLAG-or EGFP-mLPCAT1-To facilitate immunocytochemical and Western blot analysis of mLPCAT1, we constructed a fusion protein of mLPCAT1 that contained the FLAG or EGFP epitope fused in-frame to the N terminus of mLPCAT1. FLAG-or EGFP-mLpcat1 were transfected into CHO-K1 cells, and the enzyme distribution was examined by confocal microscopy after 48 h. Both FLAG-and EGFP-mLPCAT1 exhibited significant enzyme activities (data not shown). Cells were stained for ER-Golgi, mitochondria, and lysosome using DiOC 6 (3), MitoTracker Red, and LysoTracker Red, respectively. Whereas the subcellular distribution pattern of FLAG-mLPCAT1 was similar to that of DiOC 6 (3), EGFPmLPCAT1 was not co-localized with MitoTracker Red or LysoTracker Red, suggesting that the enzyme is present mainly in the ER and Golgi (Fig. 3A) . To confirm the results of microscopic observations, CHO-K1 cells transiently transfected with FLAG-mLPCAT1 were homogenized, and different subcellular fractions were collected by centrifugation. When these fractions were analyzed by Western blot using the M2 anti-FLAG antibody (Fig. 3B) , the enzyme was found mostly in a 100,000 ϫ g pellet, consistent with the confocal microscopic data (Fig. 3A) . FLAG-mLPCAT1 had an apparent molecular mass of 60 kDa, a value consistent with the molecular weight predicted from the open reading frame of mLPCAT1 (Fig. 3B) . FLAG-mLPCAT1 was also detected in a 9,000 ϫ g pellet. According to Western blot analysis using anti-calnexin antibody as an ER maker, this fraction contained ER protein to a small extent (Fig. 3B) .
Kinetics of mLPCAT1 Expressed in CHO-K1 Cells-We next examined the acyltransferase activity of mLPCAT1 using 1-palmitoyl-LPC and palmitoyl-CoA. The reaction was linear for the first few minutes at 30°C (data not shown). The pH optimum for the reaction was between 7.4 and 10, and the reaction did not require Ca 2ϩ (data not shown). Src homologyreducing reagents also had no effect on enzymatic activity (data not shown). Kinetic analysis was carried out by measuring acyl- A, ER-Golgi, mitochondria, and lysosome were visualized using DiOC 6 (3) (green), MitoTracker Red (red), and LysoTracker Red (red), respectively. FLAG-mLPCAT1 was visualized using M5 anti-FLAG peptide antibody as shown in red, and EGFP-mLPCAT1 was observed as green color. The scale bars correspond to 20 m. B, the 9,000 ϫ g pellet, 100,000 ϫ g pellet, and 100,000 ϫ g supernatant fractions from transfected CHO-K1 cells were subjected to Western blot analysis using M2 anti-FLAG antibody or anti-calnexin antibody as an ER marker. FLAG-mLPCAT1 was detected predominantly in a 100,000 ϫ g pellet, with a low level of detection in a 9,000 ϫ g pellet. Molecular sizes are indicated on the right in kDa. Results are representative of three independent experiments. (Fig. 4, A and  B) . The apparent K m values of mLPCAT1 for palmitoyl-CoA and 1-palmitoyl-LPC were 3.0 and 2.3 M, respectively. At higher concentrations of palmitoyl-CoA, enzymatic activity appeared to be inhibited, possibly due to a detergent effect. Thus, the mLPCAT1 cDNA, when expressed in CHO-K1 cells, conferred significant LPCAT activity, using palmitoyl-CoA and 1-palmitoyl-LPC as substrates.
Substrate Selectivity of mLPCAT1-Using [1-14 C]palmitoylCoA as an acyl donor, we analyzed the substrate specificity of mLPCAT1 using a variety of lysophospholipid acceptors (Fig.  5A) . The microsomal fraction from CHO-K1 cells transfected with mLPCAT1 had detectable LPCAT activity in the presence of 1-acyl-LPC (Fig. 5A ). 1-O-Alkyl-LPC, 1-O-alkenyl-LPC, and 1-acyl-LPG also served as acyl acceptors (supplemental figure). There also appeared to be endogenous acyltransferase activity toward 1-acyl-LPA and 1-acyl-LPC in CHO-K1 cells (open bars in Fig. 5A ).
Next, we examined the preference of mLPCAT1 for various acceptor acyl groups at the sn-1 position of LPC, using [1- 14 C]palmitoyl-CoA as an acyl donor. As seen in Fig. 5B , mLPCAT1 recognized medium to long chain LPCs (C14:0 Ͼ C16:0 Ͼ C18:1 Ͼ C12:0, C18:0) as substrates.
We then examined the acyl-CoA selectivity of mLPCAT1 using [1- 14 C]palmitoyl-LPC as an acceptor (Fig. 5C ). mLP-CAT1 demonstrated a clear preference for medium to long chain and saturated fatty acyl-CoAs (C10:0 Ͼ C8:0, C12:0 Ͼ C6:0, C14:0, C16:0). In addition, there was significant enzymatic activity toward C18 and C22 unsaturated fatty acyl-CoAs (Fig. 5C and supplemental materials Fig. A) . In contrast, there was poor activity using short chain (C2 to C4) saturated fatty acyl-CoAs. Note that CHO-K1 cells had significant endogenous LPCAT activity toward long chain unsaturated fatty acylCoAs (open bars in Fig. 5C ). These results suggested that the mLPCAT1 gene encoded an LPC acyltransferase with a preference for saturated acyl-CoAs.
Presence of LPCAT1 in Rat Alveolar Type II Cells-The high expression level of Lpcat1 in the mouse lung (Fig. 2) , and its catalytic activity in producing both dipalmitoylphosphatidylcholine (DPPC) and phosphatidylglycerol (PG), strongly suggested that the enzyme would be present in alveolar type II cells. We isolated alveolar type II cells from the rat lung, because standard procedures for their isolation have been established (34) , and a significant number of cells could be obtained. As shown in supplemental Fig. B , rat alveolar type II cells have typical structures, including intracellular lamellar bodies. Lpcat1 was enriched in this cell type, as determined by both quantitative RT-PCR (Fig. 6A ) and enzyme assays using 1-palmitoyl-LPC and palmitoyl-CoA as substrates (Fig. 6B) . Alveolar macrophages, which are another major cellular component of the lung, were obtained by lung lavage. Whereas Lpcat1 was not expressed in these cells (Fig. 6A) , they exhibited LPCAT activity (Fig. 6B) , possibly due to other types of lysophospholipid acyltransferases.
DISCUSSION
Pulmonary surfactant is a mixture of lipids and surfactant proteins secreted from alveolar type II cells (for reviews, see Ref. 35 and 36) . It provides a low surface tension at the airliquid interface for efficient gas exchange and alveolar stability. Both genetic and acquired deficiencies in pulmonary surfactant cause severe respiratory failure, which is manifest as acute respiratory distress syndrome, pneumonia, or neonatal respiratory distress syndrome (37, 38) . Surfactant lipids also serve as binding and entry molecules for non-enveloped adenoviruses during common respiratory infections (39) . Therefore, the production of surfactant lipids, especially DPPC, is highly regulated in vivo. Whereas there has been extensive analyses of surfactant proteins A, B, C, and D (38, 40) , very little information is available on the mechanisms of production of surfactant lipids. Extensive analysis of surfactant composition revealed that there is 40% DPPC, and other PC, and that it contains 10% PG (41) . Essentially, three distinct biosynthetic pathways are proposed to contribute to the composition of surfactant: 1) de novo biosynthesis, 2) remodeling by LPC or LPG acyltransferases, and 3) CoA-independent transacylation with 2 molecules of LPC (1, 2, 42-48). In an attempt to understand the relative contribution of each of these three pathways, we have isolated an enzyme that is involved in the production of both PC and PG via the remodeling pathway. By searching the genomic data base using conserved motifs of LPA acyltransferases (27) and tafazzins as queries, we identified a cDNA that encoded a protein of 534 amino acid residues, and had a predicted molecular mass of 60 kDa (Figs. 1 and 3B ). It contained three motifs, motif 1 (HSSYFD), motif 2 (GTLIQ/RYIR), and motif 3 (PEGTC), that are conserved among three species (Fig. 1) , and are possibly involved in catalytic activity. 4 Using a heterologous overexpression system, we found that the enzyme was predominantly located in the ER-Golgi complex (Fig. 3) . Whereas the small amount of mLPCAT1 was found in a 9.000 ϫ g pellet (Fig. 3B) , this could be due to the crosscontamination of ER protein in this fraction. In fact, calnexin, an ER maker was observed to the some extent in this fraction (data not shown). Thus, although there appears to be ER-Golgi-specific localization, the exact location of the endogenous protein in native cells remains to be determined.
The protein was highly expressed in alveolar type II cells of the rat lung (Fig. 6) , and exhibited significant LPCAT activity, with a preference for medium chain (C6 to 14) saturated and long chain unsaturated fatty acyl-CoAs (Fig. 5C ) in vitro. However, in alveolar type II cells, palmitoyl-CoA constitutes about 40% of all acyl-CoAs, and the medium chain acyl-CoAs are rarely seen in vivo (49) . This is significant, because substrate availability determines the molecular species of PC in surfactant. It is interesting to note that mLPCAT1 also used LPG as an acceptor (Fig. 5A) , because pulmonary surfactant contains PG, in addition to DPPC (41) . Elucidation of the roles of mLPCAT1 in the production of components of surfactant, and in other biological processes awaits gene-targeting studies. It is also important to note that CHO-K1 cells have endogenous LPCAT activity, especially for long chain unsaturated fatty acyl-CoA donors (open bars in Fig. 5C ). The identity of the endogenous enzyme(s) responsible for this activity is unknown, but these results point to enzymes involved in the deacylation and reacylation cycle (Lands' cycle) that occurs in various biological membranes (2) (3) (4) . Further studies are needed to elucidate the roles of mLPCAT1 in vivo, and determine its potential as a therapeutic target for diseases involving surfactant dysfunction. Finally, the molecular identification and characterization of the first LPCAT paves the way for a better understanding of the biochemical mechanism underlying phospholipid biosynthesis.
